MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-08
DOI
10.1038/s41388-019-1045-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
- (2019) Alessandro Carugo et al. CANCER CELL
- Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma
- (2019) Zhixiong Cai et al. CLINICAL CANCER RESEARCH
- Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells
- (2018) Brian J. Morrison et al. BMC CANCER
- HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway
- (2018) Wei Yang et al. CANCER LETTERS
- Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
- (2018) Aurélie Durgeau et al. Frontiers in Immunology
- Replication Stress: An Achilles' Heel of Glioma Cancer Stem–like Cells
- (2018) Meredith A. Morgan et al. CANCER RESEARCH
- Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome
- (2018) Scott D. Brown et al. OncoImmunology
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Immunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studies
- (2015) Gaetano Finocchiaro et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy
- (2015) Chien-Chung Chang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance
- (2014) Wei Yang et al. EXPERIMENTAL CELL RESEARCH
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Pathological features of highly invasive glioma stem cells in a mouse xenograft model
- (2013) Hirokazu Sadahiro et al. Brain Tumor Pathology
- Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
- (2013) Einar Osland Vik-Mo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- p53 increases MHC class I expression by upregulating the endoplasmic reticulum aminopeptidase ERAP1
- (2013) Bei Wang et al. Nature Communications
- Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
- (2011) Karrune V Woan et al. IMMUNOLOGY AND CELL BIOLOGY
- Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
- (2010) T. Di Tomaso et al. CLINICAL CANCER RESEARCH
- Glioma cancer stem cells induce immunosuppressive macrophages/microglia
- (2010) Adam Wu et al. NEURO-ONCOLOGY
- Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors
- (2008) A. F. Setiadi et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now